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ABSTRACT 
Objective:To evaluate the association of 25-hydroxyvitamin D3 (25OHD)inadequacyand hyperglycaemia in a Pakistani adult population. 
Study Design:Case control study 
Place & Period of Study:Department of Pathology, PNS SHIFA Hospital, Karachi; Aug 2011 to Nov 2011. 
Method and Material:Plasma Glucose levels were measured in 86 patients divided on the basis of their 25-hydroxyvitamin D3 
(25OHD)levels in three groups, normal (>31 ng/ml), insufficient (20-31ng/ml) and deficient (<20ng/ml). Vitamin D insufficiency (VDI) 
and Vitamin D Deficiency (VDD) are collectively called Vitamin D inadequacy. 25OHD was measured by electrochemiluminescence 
using Roche Elecsys® Systems while glucose was estimated by routine methods on Roche Hitachi® Autoanalyser. 
Results:.Vitamin D levels were inversely correlated with plasma glucose levels(r=-0.38;p<0.01) with an Odd Ratio of 3.59 
(95%confidence interval 1.29 to 8.70).Fasting plasma glucose was significantly higher in VDD patientsas compared to patients with 
normal vitamin D status (p<0.05).  
Conclusion:Higher glucose levels were found more frequent in patients with Vitamin D deficiency. 
Keywords:Vitamin D3; Diabetes mellitus; Association; risk factor  
 
Introduction:Vitamin D deficiency (VDD) is a world-
wide epidemic with recent estimates indicating more than 
50% global population at risk1. This pandemic of 
inadequate vitamin D (VDD and vitamin D 
insufficiency) has been found in all age groups even in 
those who are otherwise healthy and are not prone to 
deficiency2.In Pakistan, prevalence of VDD has been 
reported up-to 92% in ambulatory patients in various 
situations3,4. The discovery of vitamin D receptors 
(VDR) in almost all the tissues has led to the 
identification of role of vitamin D in many organ systems 
of the body, instead of merely associated with bone 
disorders5. Vitamin D has also been found to play an 
important role in the disorders of glucose and insulin 
metabolism6. Inversecorrelation between serum vitamin 
D levels and glycaemic levels has been shown in many 
studies5-7.Most of this data, however, pertains to 
Caucasian populationwhilestudies in African American 
have not confirmed these findings and the association 
between VDD and diabetes mellitus (DM) is quite 
blurred8. Asians have a high prevalence of both DM and 
VDD and the association of these two disorders has been 
described in studies carried out in Asian living in the 
West9. Vitamin D replacement therapy in South Asian 
patients with diabetes has also been shown to decrease 
HbA1c and weight10. Tehraniet al (2010) has shown that 
abnormal vitamin D concentrations were more common 
in South Asians with type 2 DM (T2DM) and diabetic 
control was inversely related to vitamin D status in South 
Asian women with T2DM11. Conversely, Taylor and 
Wise (1997) have reported that vitamin D replacement 
may increase the insulin resistance and worsen the 
glycaemic control in Asians12. Pakistan is one of the 
countries with a very high burden of diabetic patients and 
a very high prevalence of hypovitaminosis D3,4. So 
present study has been planned to evaluate an association 
between these two metabolic diseases. 
Methods and Material: In this case control study 
86subjectswere selected by non-probability convenience 
sampling out of the patients (mostly Armed Forces 
Persons and their families) referred for vitamin D 
estimation. Sample size wascalculated by WHO 
calculator taking hyperglycaemia (12%) as the least 
proportion outcome variable, 5% margin of error and 
95% confidence interval. The subjects on vitamin D 
replacement therapy, patients of type1diabetes and 
patients with normoglycaemia as a result of anti-diabetic 
treatment were excluded from study. The sample 
population consisted of patients with normoglycaemia 
(NG), impaired fasting glucose (IFG), and DM. NG was 
defined as Fasting Plasma Glucose (FPG)< 5.6 mmol/L, 
IFG: 5.6 – 7.0 mmol/L and DM> 7.0 mmol/L13. 
Similarly, on the basis of their 25OHDlevels in blood the 
subjects were clustered in three groups, normal (>31 
ng/ml), insufficient (20-31ng/ml) and deficient 
(<20ng/ml)14. 25OHD was measured by 
electrochemiluminescence using Roche Elecsys® 
Systems while glucose were estimated by routine 
methods on Roche Hitachi®  
Statistical Analyses:The data was recorded in SPSS 
version 17 and frequencies of various groups of subjects 
according to Vitamin D status were determined. 
Comparison of frequencies was carried out usingChi 
Square test, while continuous data i.e. Plasma glucose 
and 25OHDwas compared by students` t test. Then 
correlation studies were carried out between FPG and 
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25OHD levels using Pearson`s Correlation Coefficient. 
VDD and vitamin D insufficiency (VDI) of vitamin D 
status groups were combined and IFG and DM of 
glucose categories were combined and then 2x2 table 
was constructed for comparison and calculation of Odd 
Ratio (OR) using chi-square test. 
Results:The sample population had a slight female 
preponderance (53%), while median age was 34 years 
(range: 19- 65 years). Vitamin D inadequacy was found 
in 27 (31%) subjects. DM was more frequent in subjects 
with VDD (50%i.e. half of the patients with VDD were 
also having DM) and VDI(31.6%) as compared to 
subjects with normal vitamin D status (6.1%)(Table 
1).Similarly, more patients with IFG were found in VDD 
(25%) and VDI (26.3%) groups as compared to subjects 
with normal Vitamin D status. Gradual worsening of 
glycaemic condition was found on progressing from 
normal vitamin D status to insufficiency and deficiency 
(Figure1).Plasma glucose was significantly higher in 
VDD patientsas compared to those subjects with normal 
vitamin D status (p < 0.05) (Table 2). Vitamin D levels 
were inversely correlated with plasma glucose levels (r=-
0.38;p< 0.01) (Table 2). Table 3 shows that Vitamin D 
inadequacy in normal and abnormal glucose groups (OR: 
3.59; 95% confidence interval 1.29-8.70 
Discussion:The association of Vitamin D and DM has 
been described for more than twenty five years now15. 
Many workers have shown evidence that vitamin D is 
related to various aspects of glucose metabolism e.g. 
improving beta-cell function of pancreas, insulin 
secretion and insulin sensitivityand is one of the most 
important environmental factors causing T2DM16-20. Our 
data has showntwo significant findings i.e. higher 
prevalence of IFG and frank DM in patients with VDI 
and VDD, and a significance correlation of FPG and 
vitamin D levels. Many cross-sectional studies carried 
out in Western populations havegenerally reported an 
inverse association between vitamin Dstatus and 
prevalent hyperglycemia21.Similar associations between 
higher fasting plasma glucose levels and vitamin D status 
were observed in a community-based study of older 
adults without known diabetes22. Expressing this 
association in another manner, Tahrani et al (2010) has 
shown that a low serum 25OHD(< 20 ng/ml) was more 
common in diabetics as compared to controls (83% vs. 
70%; p <0.07)11. In another study from US, 
mean25OHDlevels among T2DMpatients were found 
significantly lower than in individuals without 
T2DM(OR 1.85; 95% CI 1.03 – 3.32; P = 0.038)23. 
Conversely, in an Indonasian study 81% diabetic were 
found to be having VDD as compared to 75% non-
diabetic (OR: 0.8; 95% CI 0.42 – 1.21; P = 0.46)24 
whereas our study showed an OR of 3.35 (95% CI: 1.29-
8.70). This discrepancy is difficult to explain but is 
probably due to difference in age of the selected 
population.  
Theclose association between vitamin status and DM has 
been further emphasized by the finding that inadequate 
vitamin D level is an important risk factor for the 
development of type 2 DM25-28. The intervention studies 
to improve glycaemic control with certain doses of 
vitamin D, however, have shown variable results29-
30.Beneficial effectof vitamin D on T2DMis needed to be 
confirmed in large trialsspecifically designed to test the 
hypothesis that vitamin Dstatus is a direct contributor to 
the pathogenesis of T2DM.If such an intervention is 
clearly shown to be effective this could have substantial 
public health implications21. 
This was among the initial studies in our countryto 
examine the association of vitamin D status with various 
categories of glucose abnormalities but with some 
limitations e.g. impaired glucose tolerance which is a 
category of hyperglycaemia based on oral glucose 
tolerance test could not be studied. Similarly data 
regarding glycosylated hemoglobin could not be 
recorded. 
Conclusion:A significant associationbetween diabetes 
mellitus and vitamin D inadequacy exists which imply 
that vitamin D deficiency or insufficiency is undesirable 
in patients with any form of hyperglycaemia.
Table 1:  Distribution of various glycaemic groups in subjects with different Vitamin D Status 
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n= 8 2 (25%) 2 (25%) 4 (50%) Normal and 
Deficiency Group 
(p<0.001) 
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